Evidence map›Paper›PMID 36276611›Full record

ArticleAnalytical cellular pathology (Amsterdam)2022

Antitumor Effect of Demethylzeylasteral (T-96) on Triple-Negative Breast Cancer via LSD1-Mediate Epigenetic Mechanisms.

Zhengjie Shen, Yongjuan Gu, Ruiyang Jiang, Heya Qian, Siyuan Li, Lixian Xu, Wenzhe Gu, Yun Zuo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Analytical cellular pathology (Amsterdam), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhengjie ShenThe Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang 215600, China.ORCID https://orcid.org/0000-0002-7023-5652
Yongjuan GuThe Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang 215600, China.ORCID https://orcid.org/0000-0003-1337-9438
Ruiyang JiangJiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing 210023, China.ORCID https://orcid.org/0000-0002-8326-8920
Heya QianThe Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang 215600, China.ORCID https://orcid.org/0000-0003-4806-8250
Siyuan LiThe Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang 215600, China.ORCID https://orcid.org/0000-0002-2091-0138
Lixian XuThe Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang 215600, China.ORCID https://orcid.org/0000-0003-2442-9306
Wenzhe GuZhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang 215600, China.ORCID https://orcid.org/0000-0003-1383-9238
Yun ZuoThe Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang 215600, China.ORCID https://orcid.org/0000-0001-6946-9614
Soochow University · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Triple Negative Breast NeoplasmsAnimalsApoptosisCell Line, TumorCell ProliferationEpigenesis, GeneticFemaleHistone DemethylasesHistonesHumansMiceMolecular Docking SimulationPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, Small InterferingTransforming Growth Factor betademethylzeylasteralHistone DemethylasesHistonesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, Small InterferingTransforming Growth Factor betaTriterpenes

Identifiers

PMID36276611
PMCPMC9581660
OpenAlexW4304776309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.